TEM announces the acquisition of Deep 6 AI, enhancing its AI-driven clinical trial matching capabilities to accelerate patient recruitment and revolutionize precision medicine.

The excitement around reasoning models like OpenAI’s o1 and DeepSeek’s R1 got me thinking: How much are businesses actually using them?The answer might be: not as much as you’d think.When I ask ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

The firm is making waves in the AI space with its announcement on Wednesday that says it will become the first company in ...

Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector.

The digital health IPO market has slowed to a crawl in recent years, but it could be poised for a turnaround in 2025, experts ...

AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

In the article appearing in the AACR Journal, researchers at the Henry Ford Health Pancreatic Cancer Center, found that Black ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has acquired Deep 6 AI, a leading AI-powered precision ...

Medical imaging is a broad term that encompasses several distinct technologies. After working on AI-powered tools to enhance ...

We recently published a list of Top 10 Stocks Everyone Is Talking About These Days. In this article, we are going to take a ...

Cathie Wood‘s Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA) , Palantir Technologies Inc. (NASDAQ:PLTR ...